Skip to main content
. 2017 Feb 8;12(2):e0171344. doi: 10.1371/journal.pone.0171344

Table 2. Subject characteristics.

Healthy subjects (n = 30) COPD (n = 32) IPF (n = 15)
Age, yrs 55(9) 63(9)*** 72(9)***°
Gender (M/F) 11/19 24/8 12/3
Height, cm 169(8) 171(9) 170(12)
Weight, Kg 72(12) 71(17) 76(13)
BMI, Kg/m2 25(3) 24(4) 26(3)
Smokers (Never/ex/Current), n 13/8/9 1/17/14 2/10/3
pack-yr 9(13) 47(32)*** 33(24)**
FEV1%pred 111(11) 49(16) 69(15)
FVC %pred 114(15) 81(14) 69(16)
FEV1/FVC % 80(4) 48(10) 76(11)
TLC, %pred nd 115(19) 68(14)
RV, %pred nd 192(58) 65(49)°°°
DLCO %pred nd 56(14) 36(16)°
KCO %pred nd 76(20) 59(16)
ICS (yes/no) 0/30 12/20 3/12
OCS (yes/no) 0/30 2/30 2/13

Data are expressed as mean (SD).

* p < 0.05 compared to healthy subjects.

** p < 0.001 compared to healthy subjects.

*** p < 0.0001 compared to healthy subjects.

° p < 0.05 compared to COPD.

°° p < 0.001 compared to COPD.

°°° p < 0.0001 compared to COPD.

FEV1: forced expiratory volume in one second; FVC: forced vital capacity; TLC: total lung capacity; RV: residual volume; DLCO: diffusion capacity of CO in the lung; ICS: inhaled corticosteroid; OCS: oral corticosteroid.